BioSpace News Archive

Calysta, Inc. World-leading alternative protein producer, Calysta, has signaled its future intentions with the appointment of food and feed innovation veteran Dr Geoff Bryant as Chief Technology Officer. Dr Geoff Bryant has more than 20 years’ experience in leading R&D and technology teams, most recently as Quorn Foods Technical and Innovation Director and previously with Mars Inc. Based at Calysta’s UK T

Halberd Corporation announced Arizona State University commenced its research work for Halberd Corp.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, plans to present a corporate overview and provide information about edasalonexent, in Phase 3 development for the treatment of Duchenne muscular dystrophy, at the following virtual investor conferences this month: HC Wainwright 22 nd Annual Global Investment Conf

CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy Research Agreement with UMass Medical School

Bardy Diagnostics, Inc., (“BardyDx”), a leading developer and provider of remote ambulatory cardiac monitoring and digital health solutions, announced today the appointment of Kevin Hykes as President and Chief Executive Officer, effective August 31, 2020 . Hykes will also become a member of BardyDx’s Board of Directors. With over 28

Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it will hold its 2020 Annual General Meeting of Shareholders (the “AGM”) at its new headquarters, Room 1202, Building B, Zhihui Guangchang, 4068 Qiaoxiang Road, Nanshan District, Shenzhen, P.R.C., at 3 p.m. (China Standard Time) on September 15, 2020

Company Demonstrates Initial Comparability Between TARA-002 and OK-432, Advancing to Final GMP Comparability Runs

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced that management will host an investor conference call to discuss AUTO3 data presented at the European Society for Medical Oncology Virtual Congress 2020 and to participate in Banking conferences through September

Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences

Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the Morgan Stanley Virtual Global Healthcare Conference on Tuesday, September 15, 2020 at 2:00 p.m. Eastern Time.